Vericel Corp Ord Stock Buy Hold or Sell Recommendation
| VCEL Stock | USD 54.00 3.97 7.94% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Vericel Corp Ord is 'Hold'. The recommendation algorithm takes into account all of Vericel Corp's available fundamental, technical, and predictive indicators you will find on this site.
Check out Vericel Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Vericel and provide practical buy, sell, or hold advice based on investors' constraints. Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Vericel |
Execute Vericel Corp Buy or Sell Advice
The Vericel recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vericel Corp Ord. Macroaxis does not own or have any residual interests in Vericel Corp Ord or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vericel Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Vericel Corp Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 197.52 M. Net Loss for the year was (3.18 M) with profit before overhead, payroll, taxes, and interest of 109.79 M. | |
| Vericel Corp Ord has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from investing.com: Disposition of 5000 shares by Joseph Mara of Vericel Corp at 50.0 subject to Rule 16b-3 |
Vericel Corp Returns Distribution Density
The distribution of Vericel Corp's historical returns is an attempt to chart the uncertainty of Vericel Corp's future price movements. The chart of the probability distribution of Vericel Corp daily returns describes the distribution of returns around its average expected value. We use Vericel Corp Ord price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vericel Corp returns is essential to provide solid investment advice for Vericel Corp.
| Mean Return | 0.19 | Value At Risk | -3.99 | Potential Upside | 4.58 | Standard Deviation | 2.71 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vericel Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vericel Stock Institutional Investors
| Shares | Loomis, Sayles & Company Lp | 2024-06-30 | 1.1 M | Bnp Paribas Investment Partners Sa | 2024-06-30 | 1 M | Macquarie Group Ltd | 2024-06-30 | 1 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 910.7 K | William Blair Investment Management, Llc | 2024-06-30 | 908.1 K | Federated Hermes Inc | 2024-06-30 | 840.8 K | Rtw Investments, Llc | 2024-06-30 | 801.4 K | Royal Bank Of Canada | 2024-06-30 | 762 K | Geneva Capital Management | 2024-06-30 | 684.3 K | Blackrock Inc | 2024-06-30 | 8.1 M | Brown Capital Management, Llc | 2024-06-30 | 4.4 M |
Vericel Corp Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 8.7M | 6.9M | 34.7M | (17.5M) | 35.8M | 37.6M | |
| Free Cash Flow | (9.8M) | 14.9M | 21.1M | 10.1M | 7.8M | 8.2M | |
| Depreciation | 1.7M | 2.4M | 3.0M | 4.0M | 4.6M | 4.9M | |
| Other Non Cash Items | 2.8M | 4.4M | 4.4M | 3.7M | (369K) | (350.6K) | |
| Capital Expenditures | 2.6M | 2.6M | 7.9M | 7.6M | 27.5M | 28.9M | |
| Net Income | (9.7M) | 2.9M | (7.5M) | (16.7M) | (3.2M) | (3.3M) | |
| End Period Cash Flow | 27.0M | 33.8M | 68.5M | 51.1M | 86.9M | 91.2M | |
| Change To Inventory | (3.3M) | (2.5M) | (4.0M) | (2.6M) | 2.9M | 3.0M | |
| Change Receivables | (8.7M) | (2.3M) | (2.9M) | (9.1M) | (8.2M) | (7.8M) | |
| Change To Netincome | 13.2M | 13.9M | 34.3M | 37.2M | 42.8M | 44.9M | |
| Investments | 13.2M | (14.5M) | 4.4M | (36.2M) | (16.8M) | (17.6M) |
Vericel Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vericel Corp or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vericel Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vericel stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 1.70 | |
σ | Overall volatility | 2.75 | |
Ir | Information ratio | 0.0001 |
Vericel Corp Volatility Alert
Vericel Corp Ord currently demonstrates below-average downside deviation. It has Information Ratio of 0.0 and Jensen Alpha of -0.12. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vericel Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vericel Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vericel Corp Fundamentals Vs Peers
Comparing Vericel Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vericel Corp's direct or indirect competition across all of the common fundamentals between Vericel Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vericel Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vericel Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vericel Corp to competition |
| Fundamentals | Vericel Corp | Peer Average |
| Return On Equity | 0.0036 | -0.31 |
| Return On Asset | -0.007 | -0.14 |
| Profit Margin | 0 % | (1.27) % |
| Operating Margin | (0.11) % | (5.51) % |
| Current Valuation | 2.35 B | 16.62 B |
| Shares Outstanding | 49.03 M | 571.82 M |
| Shares Owned By Insiders | 0.93 % | 10.09 % |
| Shares Owned By Institutions | 99.07 % | 39.21 % |
| Number Of Shares Shorted | 3.85 M | 4.71 M |
| Price To Earning | 357.33 X | 28.72 X |
| Price To Book | 9.70 X | 9.51 X |
| Price To Sales | 10.98 X | 11.42 X |
| Revenue | 197.52 M | 9.43 B |
| Gross Profit | 109.79 M | 27.38 B |
| EBITDA | (1.83 M) | 3.9 B |
| Net Income | (3.18 M) | 570.98 M |
| Cash And Equivalents | 100.69 M | 2.7 B |
| Cash Per Share | 2.13 X | 5.01 X |
| Total Debt | 88.14 M | 5.32 B |
| Debt To Equity | 0.28 % | 48.70 % |
| Current Ratio | 6.20 X | 2.16 X |
| Book Value Per Share | 4.97 X | 1.93 K |
| Cash Flow From Operations | 35.31 M | 971.22 M |
| Short Ratio | 10.05 X | 4.00 X |
| Earnings Per Share | 0.01 X | 3.12 X |
| Target Price | 57.14 | |
| Number Of Employees | 314 | 18.84 K |
| Beta | 1.67 | -0.15 |
| Market Capitalization | 2.36 B | 19.03 B |
| Total Asset | 353.66 M | 29.47 B |
| Retained Earnings | (403.18 M) | 9.33 B |
| Working Capital | 159.88 M | 1.48 B |
| Current Asset | 21.1 M | 9.34 B |
Note: Acquisition by Colangelo Dominick of 17500 shares of Vericel Corp at 3.02 subject to Rule 16b-3 [view details]
Vericel Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vericel . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vericel Corp Buy or Sell Advice
When is the right time to buy or sell Vericel Corp Ord? Buying financial instruments such as Vericel Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vericel Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corporate ETFs Thematic Idea Now
Corporate ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Corporate ETFs theme has 216 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Vericel Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.01 | Revenue Per Share 4.464 | Quarterly Revenue Growth 0.147 | Return On Assets (0.01) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.